SELL and B-cell chronic lymphocytic leukemia: These phenotypical changes indicate that these CLL cells become activated and consequently, more aggressive as shown by enhanced CD38 and ZAP-70 expression, and more likely to interact with other cells as shown by enhanced CD49d and CD62L expression.